Mohamed Elhamri

805 total citations
44 papers, 507 citations indexed

About

Mohamed Elhamri is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Mohamed Elhamri has authored 44 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 18 papers in Public Health, Environmental and Occupational Health and 13 papers in Oncology. Recurrent topics in Mohamed Elhamri's work include Acute Myeloid Leukemia Research (34 papers), Acute Lymphoblastic Leukemia research (18 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Mohamed Elhamri is often cited by papers focused on Acute Myeloid Leukemia Research (34 papers), Acute Lymphoblastic Leukemia research (18 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Mohamed Elhamri collaborates with scholars based in France and United States. Mohamed Elhamri's co-authors include Xavier Thomas, Mauricette Michallet, Youcef Chelghoum, Isabelle Tigaud, Maël Heiblig, Adriana Pleșa, Bernard Ferrier, Gabriel Baverel, Hervé Dombret and Eric Wattel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Mohamed Elhamri

42 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Elhamri France 14 323 181 159 114 91 44 507
Lucı́a Villalón Spain 11 224 0.7× 63 0.3× 107 0.7× 30 0.3× 142 1.6× 25 400
Habib M. Ghaddar United States 10 173 0.5× 124 0.7× 124 0.8× 65 0.6× 45 0.5× 14 389
Yajamanam Badrinath India 14 298 0.9× 131 0.7× 116 0.7× 266 2.3× 110 1.2× 45 548
Yasunobu Sakai United States 6 326 1.0× 107 0.6× 266 1.7× 100 0.9× 68 0.7× 7 526
Yasukazu Kawai Japan 11 194 0.6× 253 1.4× 78 0.5× 77 0.7× 59 0.6× 38 487
Victor Hoffbrand United Kingdom 11 203 0.6× 73 0.4× 36 0.2× 90 0.8× 176 1.9× 18 393
Eiju Negoro Japan 11 107 0.3× 136 0.8× 79 0.5× 38 0.3× 40 0.4× 39 318
Capizzi Rl United States 7 176 0.5× 127 0.7× 119 0.7× 128 1.1× 47 0.5× 16 423
Stephen I. Bulova United States 10 140 0.4× 94 0.5× 107 0.7× 31 0.3× 47 0.5× 20 344
Lidija Dokmanović Serbia 13 114 0.4× 145 0.8× 88 0.6× 163 1.4× 61 0.7× 47 419

Countries citing papers authored by Mohamed Elhamri

Since Specialization
Citations

This map shows the geographic impact of Mohamed Elhamri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Elhamri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Elhamri more than expected).

Fields of papers citing papers by Mohamed Elhamri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Elhamri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Elhamri. The network helps show where Mohamed Elhamri may publish in the future.

Co-authorship network of co-authors of Mohamed Elhamri

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Elhamri. A scholar is included among the top collaborators of Mohamed Elhamri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Elhamri. Mohamed Elhamri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Xavier, Gaëlle Fossard, Mohamed Elhamri, et al.. (2020). LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020020–e2020020. 2 indexed citations
2.
Thomas, Xavier, Mohamed Elhamri, & Maël Heiblig. (2020). Emerging pharmacotherapies for elderly acute myeloid leukemia patients. Expert Review of Hematology. 13(6). 619–643. 8 indexed citations
3.
Paubelle, Étienne, Adriana Pleșa, Sandrine Hayette, et al.. (2019). Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1. SHILAP Revista de lepidopterología. 7(2). 121–130. 8 indexed citations
4.
Heiblig, Maël, Mohamed Elhamri, Marie Balsat, et al.. (2016). Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience. Leukemia & lymphoma. 58(1). 110–117. 10 indexed citations
5.
Heiblig, Maël, Mohamed Elhamri, Alexandre Deloire, et al.. (2016). Acute myeloid leukemia in the elderly (age 70 yr or older): long‐term survivors. European Journal Of Haematology. 98(2). 134–141. 5 indexed citations
6.
Heiblig, Maël, Mohamed Elhamri, Franck E. Nicolini, et al.. (2015). Effect of Initial Body Mass Index on Survival Outcome of Patients With Acute Leukemia: A Single-Center Retrospective Study. Clinical Lymphoma Myeloma & Leukemia. 15. S7–S13. 7 indexed citations
7.
Elhamri, Mohamed, et al.. (2015). Effect of Valproate and of Two of Its Metabolites on Renal Substrate Uptake and Ammoniagenesis in the Rat in vivo. Contributions to nephrology. 110. 41–45.
8.
Karam, Maroun, Morgan Thénoz, David Sibon, et al.. (2014). Chromatin Redistribution of the DEK Oncoprotein Represses hTERT Transcription in Leukemias. Neoplasia. 16(1). 21–W14. 11 indexed citations
9.
Thomas, Xavier, Youcef Chelghoum, Giovanna Cannas, et al.. (2011). Leukocytosis and Circulating Blasts in Older Adults With Newly Diagnosed Acute Myeloid Leukemia: Are They Valuable Factors for Therapeutic Decision-Making?. Clinical Lymphoma Myeloma & Leukemia. 11(4). 342–349. 7 indexed citations
10.
Elhamri, Mohamed, Isabelle Tigaud, Youcef Chelghoum, et al.. (2011). Minimally differentiated acute myeloid leukemia (FAB AML-M0): Prognostic factors and treatment effects on survival—A retrospective study of 42 adult cases. Leukemia Research. 35(8). 1027–1031. 3 indexed citations
11.
Poncet, Delphine, David Pérol, Claude Preudhomme, et al.. (2010). Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias. Experimental Hematology. 39(2). 195–202.e2. 35 indexed citations
12.
Le, Quoc‐Hung, Youcef Chelghoum, Mohamed Elhamri, et al.. (2008). Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience. 2(3). 198–204. 9 indexed citations
13.
Le, Quoc‐Hung, Youcef Chelghoum, Mohamed Elhamri, et al.. (2007). Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.. Blood. 110(11). 4352–4352. 2 indexed citations
14.
Chelghoum, Youcef, et al.. (2006). Trisomy 8 as sole anomaly or with other clonal aberrations in acute myeloid leukemia: Impact on clinical presentation and outcome. Leukemia Research. 31(1). 67–73. 9 indexed citations
15.
Thomas, Xavier, Quoc‐Hung Le, Emmanuelle Tavernier, et al.. (2005). Gemtuzumab Ozogamicin (Mylotarg®) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).. Blood. 106(11). 4598–4598. 2 indexed citations
16.
Thomas, Xavier, Mohamed Elhamri, Youcef Chelghoum, et al.. (2005). Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial. Annals of Hematology. 84(6). 376–382. 7 indexed citations
17.
Tavernier, Emmanuelle, Quoc‐Hung Le, Mohamed Elhamri, & Xavier Thomas. (2003). Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors. Leukemia Research. 27(3). 205–214. 16 indexed citations
18.
Chelghoum, Youcef, et al.. (2003). Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Annals of Hematology. 82(11). 684–690. 15 indexed citations
19.
Martin, Guy, Bernard Ferrier, Marielle Martin, et al.. (1996). Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicology. Cell Biology and Toxicology. 12(4-6). 283–287. 5 indexed citations
20.
Elhamri, Mohamed, Bernard Ferrier, Marielle Martin, & Gabriel Baverel. (1993). Effect of valproate, sodium 2-propyl-4-pentenoate and sodium 2-propyl-2-pentenoate on renal substrate uptake and ammoniagenesis in the rat.. Journal of Pharmacology and Experimental Therapeutics. 266(1). 89–96. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucı́a Villalón Breakdown of academic impact, for papers by Habib M. Ghaddar Breakdown of academic impact, for papers by Yajamanam Badrinath Breakdown of academic impact, for papers by Yasunobu Sakai Breakdown of academic impact, for papers by Yasukazu Kawai Breakdown of academic impact, for papers by Victor Hoffbrand Breakdown of academic impact, for papers by Eiju Negoro Breakdown of academic impact, for papers by Capizzi Rl Breakdown of academic impact, for papers by Stephen I. Bulova Breakdown of academic impact, for papers by Lidija Dokmanović
Rankless by CCL
2026